Log in to save to my catalogue

A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and...

A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2287524830

A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge

About this item

Full title

A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge

Publisher

Netherlands: Elsevier Ltd

Journal title

Vaccine, 2019-09, Vol.37 (42), p.6162-6170

Language

English

Formats

Publication information

Publisher

Netherlands: Elsevier Ltd

More information

Scope and Contents

Contents

AbstractBackgroundFlu vaccines administered intramuscularly (IM) have shown seasonally fluctuating efficacy, 20–60%, throughout the last 15 years. We formulated a recombinant H5 (rH5) in our Nanovax® (NE01) (rH5/NE01) adjuvant for intranasal vaccination in ferrets. We evaluated the regimen, one vs two immunization, and cross clade protection a ferr...

Alternative Titles

Full title

A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2287524830

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2287524830

Other Identifiers

ISSN

0264-410X

E-ISSN

1873-2518

DOI

10.1016/j.vaccine.2019.08.071

How to access this item